טוען...
Genetics of diffuse large B-cell lymphoma
Diffuse large B-cell lymphoma (DLBCL), the most frequent subtype of lymphoid malignancy, remains a significant clinical challenge, as ∼30% of patients are not cured. Over the past decade, remarkable progress has been made in the understanding of the pathogenesis of this disease, spurred by the imple...
שמור ב:
| הוצא לאור ב: | Blood |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society of Hematology
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5969374/ https://ncbi.nlm.nih.gov/pubmed/29666115 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2017-11-764332 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|